Pace of Influenza Activity Picking Up Across the United States

Share this content:
Pace of Influenza Activity Picking Up Across the United States
Pace of Influenza Activity Picking Up Across the United States

FRIDAY, Jan. 13, 2017 (HealthDay News) -- The pace of flu activity continues to quicken across the United States, and probably hasn't peaked yet, according to an assessment by the U.S. Centers for Disease Control and Prevention.

Right now, the heaviest flu activity is occurring along the East and West Coasts, Lynnette Brammer, M.P.H., a CDC epidemiologist, told HealthDay. "The Northwest has been hit harder and earlier, and activity could have peaked there, but we won't know that for a couple of weeks," she said.

Only the center of the country has been largely spared, but Brammer expects flu activity to increase there over the next several weeks. The dominant strain right now is H3N2, which often signals a severe season that affects the oldest and youngest people the hardest, she said. H1N1 and B viruses are also circulating.

"We may be approaching a peak in H3N2 viruses, but H1N1 viruses could increase as the H3s go down," Brammer said. "And it's not uncommon to see a second wave of influenza B, because right now we haven't seen much B." This year's vaccine contains all the circulating viruses, she added, but it may be less effective against the H3N2 virus.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Single-Payer Health System Bill Moves Forward in California

Single-Payer Health System Bill Moves Forward in California

Not yet clear where money for the single-payer system would come from

Regorafenib Approved for Hepatocellular Carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

It is the first approved treatment for HCC in almost a decade

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab

is free, fast, and customized just for you!

Already a member?

Sign In Now »